Thursday, January 26th, 2023, 4:51 am
Studying the Evidence on Efficacy and Safety at Long Last?
Filed under: New video:
Description: (for backup; Google censors his videos sometimes)
JCVI makes interim recommendations to government on the COVID-19 vaccination programme for 2023.
https://www.gov.uk/government/news/jcvi-advises-an-autumn-covid-19-vaccine-booster
https://www.gov.uk/government/collections/covid-19-vaccination-programme
Joint Committee on Vaccination and Immunisation (JCVI)
has advised that plans should be made for those at higher risk of severe COVID-19 to be offered a booster vaccination this autumn (2023).
Professor Wei Shen Lim, Chair of COVID-19 vaccination on the JCVI
As the transition continues away from a pandemic emergency response towards pandemic recovery,
In England, the closure of the autumn booster campaign and the first booster offer will be on 12 February 2023.
(basically no more boosters for healthy under 50s)
Similarly, the JCVI is advising that the primary course COVID-19 vaccination should move,
over the course of 2023, towards a more targeted offer
Coronavirus (COVID-19) vaccine
https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccination/coronavirus-vaccine/
Everyone aged 5 (on or before 31 August 2022) and over can get a 1st and 2nd dose of the COVID-19 vaccine.
https://www.sst.dk/en/English/Corona-eng/Vaccination-against-COVID-19
we recommend vaccination of people aged 50 years and over as well as selected risk groups.
Regulator funding
https://www.bmj.com/content/377/bmj.o1538
Industry money saturates the globe’s leading regulators.
